KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,614 | +0.5% | 116 | +28.9% | 0.00% | 0.0% |
| Q2 2023 | $19,517 | -3.2% | 90 | -18.9% | 0.00% | 0.0% |
| Q1 2023 | $20,162 | -26.7% | 111 | -20.7% | 0.00% | -33.3% |
| Q4 2022 | $27,510 | -43.9% | 140 | -35.8% | 0.00% | -62.5% |
| Q3 2022 | $49,000 | +122.7% | 218 | +23.2% | 0.01% | +100.0% |
| Q2 2022 | $22,000 | -29.0% | 177 | -26.9% | 0.00% | -20.0% |
| Q1 2022 | $31,000 | -59.2% | 242 | -58.3% | 0.01% | -58.3% |
| Q4 2021 | $76,000 | – | 580 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |